4 Pathophysiology of fibrinolysis-Reference-Cited by-同舟云学术

4 Pathophysiology of fibrinolysis

Published:1995-06 Issue:2 Volume:8 Page:329-343
ISSN:0950-3536
Container-title:Baillière's Clinical Haematology
language:en
Short-container-title:Baillière's Clinical Haematology

Author:

Juhan-Vague Irene,Alessi Marie-Christine,Declerck Paul J.

Publisher

Elsevier BV

Subject

Hematology

Reference109 articles.

1. Fibrinogen ‘New York’—An abnormal fibrinogen associated with thrombo embolism—Functional evaluation;Al-Mondhiry;Blood,1975

2. Plasminogen activator inhibitor 1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin;Anfosso;Journal of Clinical Investigation,1993

3. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism;Angles-Cano;Journal of Laboratory Clinical Medicine,1993

4. The α2 plasmin inhibitor levels in liver diseases;Aoki;Clinical and Chimica Acta,1978

5. Abnormal plasminogen. A hereditary molecular abnormality found in a patients with recurrent thrombosis;Aoki;Journal of Clinical Investigation,1978

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrinolysis and Antifibrinolytics;Textbook of Small Animal Emergency Medicine;2018-10-07

2. Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted Serpin;Seminars in Thrombosis and Hemostasis;2013-03-16

3. t-Plasminogen Activator;Handbook of Proteolytic Enzymes;2013

4. Use of Mouse Models to Study Plasminogen Activator Inhibitor-1;Biology of Serpins;2011

5. Subtle structural differences between human and mouse PAI-1 reveal the basis for biochemical differences;Journal of Structural Biology;2010-07